Raphael Faucard

Geneve, GE 1228, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Pharmacological activity of a new ligand binding at the histamine site of the NMDA receptor in rodents.

Pharmacological activity of a new ligand binding at the histamine site of the NMDA receptor in rodents.

Journal: European journal of pharmacology

Published: August 20, 2025

Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Journal: EBioMedicine

Published: November 18, 2015

MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.

MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.

Journal: Journal of neuroimmunology

Published: October 06, 2015

Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis.

Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis.

Journal: Molecular diagnosis & therapy

Published: September 18, 2015

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up.

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up.

Journal: Journal of neuroimmunology

Published: March 19, 2015

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 13, 2014

Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672].

Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672].

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 10, 2013

Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder.

Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder.

Journal: Translational psychiatry

Published: December 06, 2012

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity.

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity.

Journal: PloS one

Published: July 26, 2012

Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.

Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 30, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026